Author:
Murad Liam,Bouhadana David,Nguyen David-Dan,Chughtai Bilal,Zorn Kevin C.,Bhojani Naeem,Elterman Dean S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Reference142 articles.
1. Ng M, Baradhi KM. Benign prostatic hyperplasia. StatPearls, Treasure Island: StatPearls Publishing; 2022.
2. Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-Initial work-up and medical management. J Urol. 2021;206:806–17. https://doi.org/10.1097/JU.0000000000002183.
3. Billet M, Windsor TA. Urinary retention. Emerg Med Clin North Am. 2019;37:649–60. https://doi.org/10.1016/j.emc.2019.07.005.
4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49. https://doi.org/10.1016/s0090-4295(02)02243-4.
5. Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). EAU Guidel., Arnhem, the Netherlands: EAU Guidelines Office; 2023.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献